Results for:(42 found)
Feb 21, 2012 1:18PM on Top StocksBy TheStockAdvisors

With 30 drugs in late-stage trials, investors are undervaluing this drug firm's long-term potential.

Tags: TEVA
Feb 17, 2012 11:43AM on Top StocksBy InvestorPlace

Not all dividend opportunities are created equal. Don't be tempted by these.

Feb 9, 2012 9:54AM on Top StocksBy TheStockAdvisors

The Israeli drugmaker has outstanding management and a history of aggressive acquisitions.

Tags: TEVA
Feb 6, 2012 2:52PM on Top StocksBy MSN Money Partner

Teva is downgraded to 'equal weight,' and MGM is downgraded to 'neutral.'

Dec 7, 2011 5:15PM on Top StocksBy Benzinga

Federal regulators nix a proposal to make the pill available without a prescription to minors.

Dec 1, 2011 12:04PM on Top StocksBy MSN Money Partner

Hewlett-Packard and Procter & Gamble are upgraded.

Nov 30, 2011 4:01PM on Top StocksBy Melly Alazraki

Its best-selling drug ever goes off patent. What's next for the world's largest drug company?

Nov 29, 2011 5:20AM on Top StocksBy Gene Marcial

The pharmaceutical company's share price reflects the bad news but not the potential positives.

Tags: TEVA



Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.